Cargando…

Effect of mistletoe on endometrial stromal cell survival and vascular endothelial growth factor expression in patients with endometriosis

Research Question: To evaluate the effect of mistletoe on the cell viability of patients with endometriosis, the expression levels of vascular endothelial growth factor (VEGF) were measured, and the change in the expression level of VEGF following mistletoe treatment was recorded. Design: Forty repr...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Jeong Min, Chung, Youn-Jee, Chae, Boah, Kang, Hee Jin, Cho, Hyun Hee, Kim, Jang Heub, Kim, Mee-Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216063/
https://www.ncbi.nlm.nih.gov/pubmed/30443175
http://dx.doi.org/10.7150/ijms.28470
_version_ 1783368272070049792
author Moon, Jeong Min
Chung, Youn-Jee
Chae, Boah
Kang, Hee Jin
Cho, Hyun Hee
Kim, Jang Heub
Kim, Mee-Ran
author_facet Moon, Jeong Min
Chung, Youn-Jee
Chae, Boah
Kang, Hee Jin
Cho, Hyun Hee
Kim, Jang Heub
Kim, Mee-Ran
author_sort Moon, Jeong Min
collection PubMed
description Research Question: To evaluate the effect of mistletoe on the cell viability of patients with endometriosis, the expression levels of vascular endothelial growth factor (VEGF) were measured, and the change in the expression level of VEGF following mistletoe treatment was recorded. Design: Forty reproductive-aged women with endometriosis (stage I/II [group 1, n=20], and stage III/IV [group 2, n=20]) were prospectively enrolled. Twenty women who underwent gynaecologic operations for benign conditions were selected as the control group. Both eutopic and ectopic endometrial tissues were obtained from the endometriosis patients. The endometrial tissues were cultured and the stromal cells were separated. The cells were cultured for 24 hours with peritoneal fluid from patients and controls with and without mistletoe supplementation (200 ng/mL), respectively. The MTT assay was used to assess cell viability, and VEGF expression was analysed by Western blotting and ELISA. Results: Using peritoneal fluid from endometriosis patients treated with mistletoe, we found that both eutopic and ectopic endometrial stromal cell viability increased after treatment with peritoneal fluid from patients with early-stage (I and II) endometriosis. After mistletoe treatment, the cell viability was decreased, in both eutopic and ectopic endometrial stromal cells in all stages of endometriosis. These findings were verified consistently by evaluating the expression and concentration of VEGF, a marker of angiogenesis. Conclusions: The present study showed that mistletoe can reduce the cell viability of endometrial stromal cells and the peritoneal fluid-induced elevation of VEGF in eutopic and ectopic endometrial stromal cells obtained from endometriosis patients, especially in the early stage. Mistletoe might have anti-angiogenic activity on endometrial stromal cells and thus is a potential candidate for the treatment of endometriosis.
format Online
Article
Text
id pubmed-6216063
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-62160632018-11-15 Effect of mistletoe on endometrial stromal cell survival and vascular endothelial growth factor expression in patients with endometriosis Moon, Jeong Min Chung, Youn-Jee Chae, Boah Kang, Hee Jin Cho, Hyun Hee Kim, Jang Heub Kim, Mee-Ran Int J Med Sci Research Paper Research Question: To evaluate the effect of mistletoe on the cell viability of patients with endometriosis, the expression levels of vascular endothelial growth factor (VEGF) were measured, and the change in the expression level of VEGF following mistletoe treatment was recorded. Design: Forty reproductive-aged women with endometriosis (stage I/II [group 1, n=20], and stage III/IV [group 2, n=20]) were prospectively enrolled. Twenty women who underwent gynaecologic operations for benign conditions were selected as the control group. Both eutopic and ectopic endometrial tissues were obtained from the endometriosis patients. The endometrial tissues were cultured and the stromal cells were separated. The cells were cultured for 24 hours with peritoneal fluid from patients and controls with and without mistletoe supplementation (200 ng/mL), respectively. The MTT assay was used to assess cell viability, and VEGF expression was analysed by Western blotting and ELISA. Results: Using peritoneal fluid from endometriosis patients treated with mistletoe, we found that both eutopic and ectopic endometrial stromal cell viability increased after treatment with peritoneal fluid from patients with early-stage (I and II) endometriosis. After mistletoe treatment, the cell viability was decreased, in both eutopic and ectopic endometrial stromal cells in all stages of endometriosis. These findings were verified consistently by evaluating the expression and concentration of VEGF, a marker of angiogenesis. Conclusions: The present study showed that mistletoe can reduce the cell viability of endometrial stromal cells and the peritoneal fluid-induced elevation of VEGF in eutopic and ectopic endometrial stromal cells obtained from endometriosis patients, especially in the early stage. Mistletoe might have anti-angiogenic activity on endometrial stromal cells and thus is a potential candidate for the treatment of endometriosis. Ivyspring International Publisher 2018-10-20 /pmc/articles/PMC6216063/ /pubmed/30443175 http://dx.doi.org/10.7150/ijms.28470 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Moon, Jeong Min
Chung, Youn-Jee
Chae, Boah
Kang, Hee Jin
Cho, Hyun Hee
Kim, Jang Heub
Kim, Mee-Ran
Effect of mistletoe on endometrial stromal cell survival and vascular endothelial growth factor expression in patients with endometriosis
title Effect of mistletoe on endometrial stromal cell survival and vascular endothelial growth factor expression in patients with endometriosis
title_full Effect of mistletoe on endometrial stromal cell survival and vascular endothelial growth factor expression in patients with endometriosis
title_fullStr Effect of mistletoe on endometrial stromal cell survival and vascular endothelial growth factor expression in patients with endometriosis
title_full_unstemmed Effect of mistletoe on endometrial stromal cell survival and vascular endothelial growth factor expression in patients with endometriosis
title_short Effect of mistletoe on endometrial stromal cell survival and vascular endothelial growth factor expression in patients with endometriosis
title_sort effect of mistletoe on endometrial stromal cell survival and vascular endothelial growth factor expression in patients with endometriosis
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216063/
https://www.ncbi.nlm.nih.gov/pubmed/30443175
http://dx.doi.org/10.7150/ijms.28470
work_keys_str_mv AT moonjeongmin effectofmistletoeonendometrialstromalcellsurvivalandvascularendothelialgrowthfactorexpressioninpatientswithendometriosis
AT chungyounjee effectofmistletoeonendometrialstromalcellsurvivalandvascularendothelialgrowthfactorexpressioninpatientswithendometriosis
AT chaeboah effectofmistletoeonendometrialstromalcellsurvivalandvascularendothelialgrowthfactorexpressioninpatientswithendometriosis
AT kangheejin effectofmistletoeonendometrialstromalcellsurvivalandvascularendothelialgrowthfactorexpressioninpatientswithendometriosis
AT chohyunhee effectofmistletoeonendometrialstromalcellsurvivalandvascularendothelialgrowthfactorexpressioninpatientswithendometriosis
AT kimjangheub effectofmistletoeonendometrialstromalcellsurvivalandvascularendothelialgrowthfactorexpressioninpatientswithendometriosis
AT kimmeeran effectofmistletoeonendometrialstromalcellsurvivalandvascularendothelialgrowthfactorexpressioninpatientswithendometriosis